- Evertz Pharma invests €10M in Bitcoin, expanding its holdings to 100 BTC as part of its financial strategy.
- First German pharma company to adopt Bitcoin as a reserve asset, indicating broader adoption beyond tech.
- Ongoing commitment since 2020, steadily allocating profits to build a Bitcoin treasury.
- Leadership views Bitcoin as a modern hedge and strategic asset for long-term resilience.
Bitcoin is no longer just the domain of tech firms and investment giants now, even natural Pharma companies are joining the digital gold rush. Evertz Pharma GmbH, a privately held German company specializing in premium natural skincare, has emerged as Germany’s first business in the Pharma industry to adopt a formal Bitcoin reserve strategy.
Marking a significant step that underscores a growing corporate shift toward decentralized finance, Evertz Pharma announced in a press release that it acquired an additional 100 BTC in May 2025, worth approximately €10 million ($10.8 million). This latest purchase marks a significant expansion of the company’s digital treasury and reflects a deepening commitment to Bitcoin as a strategic asset.
The company’s Bitcoin journey began in December 2020, when it made its first allocation of €2 million toward the cryptocurrency. Since then, Evertz Pharma has steadily redirected a portion of its corporate profits into building a BTC reserve, which now serves as a key component of its long-term financial strategy.
“Our mission is to promote natural beauty on a scientific foundation,” said Dominik Evertz, Managing Director of Evertz Pharma GmbH. “The same future-focused mindset shapes our financial strategy: Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company.”
Bitcoin Powers Evertz Pharma’s Bold Financial Strategy
The company’s adoption of a Bitcoin treasury model positions it well ahead of its industry peers and sets it apart from conventional corporate financial practices. While large publicly traded firms like MicroStrategy and Metaplanet have made headlines for their massive BTC holdings, Evertz Pharma stands out as a mid-sized, privately owned enterprise embracing digital assets not just for speculative gain, but as a safeguard for capital and a pillar of sustainable financial planning.
Tobias Evertz, Group CFO of Evertz Pharma, emphasized the long-term vision behind their BTC reserve model. “We will continue to invest corporate profits in BTC and are constantly evaluating additional ways to increase our holdings sustainably,” he said.
For the company, BTC offers more than price appreciation. It serves as a modern hedge against inflation, a portable store of value, and a reserve asset free from the storage and regulatory burdens associated with traditional commodities, such as gold.
“Bitcoin is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience. At the same time, we are aligning our financial strategy with the needs of a modern, sustainably operating company,” added Dominik Evertz.
As BTC continues to gain mainstream traction, Evertz Pharma’s bold financial approach may signal a new wave of corporate adoption in unexpected industries, where digital assets meet natural beauty in a blend of innovation and strategy.
Related | Massive Win for ADA: Cardano Officially Joins Nasdaq’s Elite Crypto Index